Hear from Chief Scientific Officer Richard Buick, PhD, as he presented on behalf of Fusion Antibodies at the Antibody Engineering and Therapeutics conference, 2025.
Your question will be sent privately to Fusion Antibodies plc. The company may choose to make this question public.
Start the conversation
Ask Fusion Antibodies plc a question about this update.
